News Detail
Bengaluru, 14 Sept 2023: Karnataka drugs controller BT Khanapure has stated that his department will immediately start investigations into the pricing violations of the anti-cancer drugs highlighted by the Bangalore District Chemists & Druggists Association and Suvarna Karnat......
View Details
Source : Pharmabiz
BT Khanapure
pricing violations
anti-cancer
Bangalore District Chemists & Druggists Association
Suvarna Karnataka Chemists & Druggists Association
Rituximab
BDCDA
SKCDA
Maball
YouTube
India Pharma Channel
NLEM
Nfiera
Zydus Celexa
Related News
- Nine hospitalised for serious skin reactions taking modafinil and armodafinil in Singapore (11-03-2025)
- 430 Narcotic Injections worth Rs 2.15 lakh seized in Surajpur; Smuggler arrested (11-03-2025)
- Adverse drug events more likely in older adults with comorbidities: Study (11-03-2025)
- Govt invites proposals for funding under PRIP scheme (11-03-2025)
- FDA Approves Celltrion’s Biosimilar to XOLAIR (11-03-2025)
- FIR in Nuh against website selling abortion kit (11-03-2025)
- Substandard drugs: Govt to mandate inspections of suppliers’ labs, warehouses (11-03-2025)
- 16,300 bottles Cough syrup worth Rs 26 lakh seized in Patna, One accused from UP arrested, driver absconding (11-03-2025)
- Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn (10-03-2025)
- Congress MP raises issue of bogus medicines in Maha Govt hospitals in Lok Sabha (10-03-2025)